These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 4401667)

  • 1. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of beta-adrenoreceptor blockade and nitroglycerin on myocardial oxygenation.
    Winbury MM; Weiss HR; Howe BB
    Eur J Pharmacol; 1971; 16(3):271-7. PubMed ID: 4399875
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade.
    Nayler WG; Carson V
    Cardiovasc Res; 1973 Jan; 7(1):22-9. PubMed ID: 4144407
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of beta-blockade on coronary and systemic circulation in dogs at rest and during adaptation to exercise.
    Ehrlich W; Schrijen FV; Krausman DT; Caldini P; Brady JV
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):213-27. PubMed ID: 4147879
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary vasomotor responses to cardiac sympathetic nerve stimulation in the dog treated with beta adrenoceptor blocking agents.
    Takenaka F; Ishihara T
    Jpn J Pharmacol; 1972 Oct; 22(5):721-3. PubMed ID: 4405463
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of three beta adrenergic receptor blockers on myocardial oxygen consumption in the dog.
    Ek L; Ablad B
    Eur J Pharmacol; 1971; 14(1):19-28. PubMed ID: 4396658
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Imamura H; Nakamura T; Kimura T
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the haemodynamic effects of propranolol, 4-hydroxypropranolol and practolol in anaesthetized dogs.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1972 Jun; 45(2):207-17. PubMed ID: 4403100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic and coronary hemodynamic effects of pronethalol practolol, sotalol and D-propranolol.
    Rowe GG; Berndt TB; O'Brien GS; Afonso S
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):5-24. PubMed ID: 4404935
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

  • 16. The haemodynamic effects of ( )-propranolol, dexpropranolol, oxprenolol, practolol and sotalol in anaesthetised dogs.
    Fitzgerald JD; Wale JL; Austin M
    Eur J Pharmacol; 1972 Jan; 17(1):123-34. PubMed ID: 4401429
    [No Abstract]   [Full Text] [Related]  

  • 17. An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.
    Singh N; Srivastava RK; Kulshrestha VK; Sinha JN; Kohli RP; Bhargava KP
    Jpn J Pharmacol; 1970 Dec; 20(4):467-72. PubMed ID: 4395619
    [No Abstract]   [Full Text] [Related]  

  • 18. Reflex and other cardiovascular changes in anesthetized dogs after beta adrenergic blockade.
    Robson RD; Lewis D; Thompson S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):662-71. PubMed ID: 4398745
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.